These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23420063)
21. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis. Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of TMPRSS4 in prostate cancer. Shi G; Yang X; Dai B; Zhang H; Shen Y; Zhu Y; Zhu Y; Xiao W; Ma C; Wen L; Qin X; Cao D; Ye D Int J Clin Exp Pathol; 2014; 7(11):8053-8. PubMed ID: 25550850 [TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of TβRII Expression in Breast Cancer. Gao N; Zhai Q; Li Y; Huang K; Bian D; Wang X; Liu C; Xu H; Zhang T PLoS One; 2015; 10(11):e0141412. PubMed ID: 26551005 [TBL] [Abstract][Full Text] [Related]
24. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection. Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment. Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109 [TBL] [Abstract][Full Text] [Related]
26. Relationship between transmembrane serine protease expression and prognosis of esophageal squamous cell carcinoma. Liu GT; Shen C; Ren XH; Yang L; Yu YM; Xiu YX; Li RH; Jiang L; Zhang CL; Li YW J Biol Regul Homeost Agents; 2017; 31(4):1067-1072. PubMed ID: 29254316 [TBL] [Abstract][Full Text] [Related]
27. Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer. Luo P; Lu G; Fan LL; Zhong X; Yang H; Xie R; Lv Z; Lv QZ; Fu D; Yang LX; Ma Y Oncol Rep; 2017 Apr; 37(4):2057-2062. PubMed ID: 28260080 [TBL] [Abstract][Full Text] [Related]
28. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921 [TBL] [Abstract][Full Text] [Related]
29. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. Tazawa H; Suzuki T; Saito A; Ishikawa A; Komo T; Sada H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Kuraoka K; Tashiro H J Gastrointest Surg; 2022 Feb; 26(2):305-313. PubMed ID: 34379296 [TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis. Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103 [TBL] [Abstract][Full Text] [Related]
31. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre. Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345 [TBL] [Abstract][Full Text] [Related]
32. Clinical implications of CIP2A protein expression in breast cancer. Yu G; Liu G; Dong J; Jin Y Med Oncol; 2013 Jun; 30(2):524. PubMed ID: 23471718 [TBL] [Abstract][Full Text] [Related]
33. Role of TMPRSS4 during cancer progression. Choi SY; Shin HC; Kim SY; Park YW Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347 [TBL] [Abstract][Full Text] [Related]
34. Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases. Megha T; Neri A; Malagnino V; Caruso S; Onorati M; Roviello F; Tosi P Cancer Biol Ther; 2010 Feb; 9(4):266-73. PubMed ID: 20026902 [TBL] [Abstract][Full Text] [Related]
35. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer. Kim S Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799 [TBL] [Abstract][Full Text] [Related]
36. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion. Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400 [TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis. Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671 [TBL] [Abstract][Full Text] [Related]
38. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer. Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302 [TBL] [Abstract][Full Text] [Related]
39. [The expression of fibroblast activation protein-α in primary breast cancer is associated with poor prognosis]. Yu H; Yang J; Li Y; Jiao S Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):370-4. PubMed ID: 25744843 [TBL] [Abstract][Full Text] [Related]
40. TMPRSS4 induces cancer cell invasion through pro-uPA processing. Min HJ; Lee MK; Lee JW; Kim S Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]